PillRx only · Ointment · Ophthalmic
Neomycin Sulfate, Polymyxin B Sulfate And Dexamethasone
Brands: Maxitrol · Neomycin And Polymyxin B Sulfates And Dexamethasone · Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.715
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
5
Active US suppliers
40%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
33K
Rx · 2026 Q1
118K
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 2 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bausch & Lomb Incorporated | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Proficient Rx LP | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Sandoz Inc | unknown | 1 | EXITED 2027 |
| Novartis Pharmaceuticals Corporation | unknown | 1 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.